Clinical Trials Act 2011

Section 28: Notification of serious adverse event or reaction

PART VI: CONDUCT OF CLINICAL TRIALS

Clinical Trials Act 2011Section 28

28. Notification of serious adverse event or reaction (1) An investigator shall, within 24 hours of becoming aware of a serious adverse event or serious adverse reaction, inform the sponsor of the event or reaction. (2) Where the sponsor receives information under subsection (1), it shall, within 24 hours, notify the Council and Pharmacovigilance Committee in writing of the serious adverse event or serious adverse reaction. (3) A sponsor shall provide such follow-up information relating to the serious adverse event or serious adverse reaction as the Council or Pharmacovigilance Committee may require. PART IX – REGISTER OF CLINICAL TRIALS

Start date not held: comes into operation on a date fixed by Proclamation, and juris holds no Proclamation for it.

as enacted (not consolidated). juris shows this Act from a copy that is not the official consolidation, so it may not carry every amendment; the amendments juris holds are listed. It does not confirm that this is the law in force today.

Ask juris about this section Official source